James Healy - Director at BioAge Labs, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
BIOA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Healy since 4/23/2024

Holdings reported by James Healy for BioAge Labs, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.23M $40.1M $18.00 Sep 27, 2024 Sofinnova Venture Partners XI, L.P.
Common Stock 26.5K $477K $18.00 Sep 27, 2024 CRESTLINE SUMMIT PINNACLE MASTER, L.P.
Common Stock 21.8K $393K $18.00 Sep 27, 2024 Crestline Summit Master, SPC - PEAK SP
Common Stock 18.4K $330K $18.00 Sep 27, 2024 CRESTLINE SUMMIT MASTER, SPC - CRESTLINE SUMMIT APEX SP
Common Stock 11.1K $200K $18.00 Sep 27, 2024 Sofinnova Synergy Master Fund LP
Stock Option (Right to Buy) 15K Sep 25, 2024 Direct Common Stock
Series D Preferred Stock 0 Sep 27, 2024 Sofinnova Venture Partners XI, L.P. Common Stock

Transactions reported by James Healy for BioAge Labs, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.